Pentwater Capital Management

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 22, 2019	Poseida Therapeutics	$142.0M Series C	Novartis Pharma	Aisling Capital, Boxer Capital, Longitude Capital, Malin Corporation, Perceptive Advisors, Vivo Capital

Total Raised

N/A

Valuation

N/A